Plus   Neg

Continental: Supervisory Board Supports Technological Transition - Quick Facts

Continental AG (CTTAY.PK) said its Supervisory Board has approved the structural adjustments at the locations in Roding and Limbach-Oberfrohna (Germany), Newport News (U.S.A.) and Pisa (Italy). The Supervisory Board also approved the structural adjustment at the Babenhausen location in Germany. Certain research and development activities in Babenhausen will be transferred to other locations by the end of 2021.

Continental AG said, with these approvals, the company will push ahead with the announced Transformation 2019-2029 program as planned.

Also, the company's management informed the Supervisory Board that discussions will be held with the local works council in Rubí (Spain) about the future prospects of the location.

Continental's CEO Elmar Degenhart said: "With its resolutions today, the Supervisory Board is supporting our urgently needed technological transition. We are focusing on profitable growth areas. These include assisted, automated and connected driving; services for mobility customers; and the tire, industrial and end-customer businesses."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Guitar Center Inc., a retailer of musical instruments, lessons, repairs and rentals, has filed for Chapter 11 bankruptcy reorganization, aiming to significantly reduce its debt and continue its business amid ongoing struggles following the coronavirus pandemic. The company, which operates nearly 300 stores across the U.S., expects to complete the process before the end of this year. Amazon is offering new "Spoiler Free" ways to keep gifts a surprise, as well as to track, receive and pick up orders this holiday season. According to the company, the new features would help customers to face the challenge of keeping those special gifts under wraps as many families are opting to stay home amid the coronavirus pandemic. AstraZeneca Plc and Oxford University's coronavirus vaccine candidate AZD1222 is found to be 70 percent effective on average against Covid-19, according to the British pharmaceutical giant. AstraZeneca plans to immediately prepare regulatory submission of the data to worldwide authorities for conditional or early approval. The company will also ask for an Emergency Use Listing from the WHO.
Follow RTT